Navigation Links
Flu focus: NIH project aims for better drugs
Date:10/20/2009

HOUSTON -- (Oct. 20, 2009) -- Rice University scientists have won a $1.5 million grant from the National Institutes of Health to scrutinize the influenza A virus for clues that could lead to more effective antiviral drugs. Strains of influenza A include this year's pandemic H1N1 variety, some seasonal varieties and the much-feared H5N1 bird flu.

Under the four-year program, biochemists in the laboratory of Rice's Jane Tao will continue their groundbreaking investigations into the form and function of nucleoprotein (NP), one of fewer than a dozen proteins encoded by the flu virus.

All varieties of influenza A consist of variants of just eight genes --encoded in RNA -- that produce 11 proteins. But for all its apparent simplicity, the disease behaves in complex ways that have stymied scientists for decades.

For instance, when flu particles dock with healthy cells, they inject their genetic payload into the cell and hijack the cell's own machinery to make copies of themselves. Based on previous research -- including an influential 2006 report by Tao and University of Texas at Austin colleague Robert Krug -- scientists know the flu can replicate only when all eight genes are packaged in a particular way. Tao, who first deciphered the atomic structure of NP for that study, said the new research program will go a step further by systematically investigating NP's role in building the RNA package that's so critical for the virus to reproduce.

"This particular form is very important for the RNA to function as a template, but we do not understand how the flu packages only the eight segments that it needs and in the right order," Tao said. "It's the specificity that's intriguing. If you package eight random segments of RNA, the chances of getting a viable virus are very low."

Scientists know that in the viable package, NPs are stacked atop one another -- much of like vertebrae in a spine -- and the RNA segments wrap around the
'/>"/>

Contact: Jade Boyd
jadeboyd@rice.edu
713-348-6778
Rice University
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. LaserCard Corporation Announces Expansion of Middle East Project
2. UD leads $5.3-million research project on rice epigenetics
3. RSC Project Prospect scoops prestigious award
4. UD leads $5.3-million research project on rice epigenetics
5. USC biomedical team to participate in $6 million low vision project
6. Green alga genome project catalogs carbon capture machinery
7. USDA Cooperative Agreement funds mosquito project at Rutgers
8. Life-saving clean water project secures $13M from Bill & Melinda Gates Foundation
9. UW launches cutting-edge DNA fin-printing project for salmon
10. BIO-key(R) PocketCop(R) Project Leading the Nation According to Televised Report
11. Are current projections of climate change-impacts on biodiversity misleading?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... mechanism by which estrogen suppresses lipid synthesis in the ... approach toward treating certain liver diseases. , With ... are changing long-held views in the field. Study results ... Science Signaling . , "The dogma in the ... only receptors located in the nucleus respond to steroid ...
(Date:5/23/2013)... unnecessarily undergo surgery or harsh treatments because science ... aggressive forms of the disease. Researchers at Case ... are developing technology that allows patients to safely ... treatments or take drastic measures. , The project ... professor of biomedical engineering at Case Western Reserve ...
(Date:5/23/2013)... of the world are billions of animal and plant ... and grasses, all stacked, stored and preserved in jars ... could be critical to understanding how the Earth,s biodiversity ... footprint if only the information were easily accessible. ... the help of a team from the University of ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4
... . . Changing the behavior of a material ... the computing power of Oak Ridge National Laboratory,s Jaguar supercomputer, ... and hydrogen to nanoribbons made of boron nitride. The added ... insulator into that of a metal. That makes ...
... hot springs are furthering efforts at the Department of ... from crops such as switchgrass. The ... expensive enzymes that break down complex plant materials to ... cheaper alternative is consolidated bioprocessing, a streamlined process that ...
... study is revealing new information about a key protein,s ... neurological disorders. This work could one day lead to ... associate professor in The University of Texas at Dallas, ... with senior neuroscience student Francisco Garcia on a series ...
Cached Biology News:ORNL story tips, February 2012 2ORNL story tips, February 2012 3ORNL explores proteins in Yellowstone bacteria for biofuel inspiration 2Study looks at possible link to hyper-excitability factors in epilepsy, autism and more 2
(Date:5/24/2013)... SAN DIEGO , May 24, 2013 ... a  company using proprietary taste science technologies to discover, ... David Linemeyer , Ph.D., the Company,s ... , Vice President, Investor Relations & Corporate Communications, will ... Friday, May 31, at 10:25 a.m. Eastern Time (7:25 ...
(Date:5/24/2013)... Vestiage, Inc. (stock symbol "VEST") ... science-based research and development, sales and marketing of ... announced today that it is awarding exclusive Vestiage ... of Reluma Skin Illuminating Facial Care. Qualified applicants ... sending an email to info(at)vestiageinc(dot)com and putting RELUMA ...
(Date:5/23/2013)... , May 23, 2013 Venaxis, Inc. (Nasdaq: ... focused on obtaining FDA clearance and commercializing its rapid, ... the pricing of an underwritten public offering of 10,000,000 ... purchase 3,500,000 shares of its common stock at an ... public offering price of $1.25 per share and related ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Patheon ... manufacturing services to the global pharmaceutical industry, will host ... Novel Approaches to Testing” on Tuesday, June 4, 2013 ... pharmaceutical manufacturers are required to comply with regulations for ... practices with limited scientific underpinning and little evaluation of ...
Breaking Biology Technology:SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2
... IL-8 and Future ... in Cancer and Inflammation, COPENHAGEN, September 13 ... antibody is directed,to IL-8 (interleukin-8) and may have potential ... studies to treat glioblastoma,a cancer of the central nervous ...
... - Physicians Welcome New Option ... has a Rapidly Bactericidal Mode of Action ... treatment of both,methicillin-sensitive and resistant Staphylococcus aureus ... infections (right-sided,infective endocarditis) has been announced today ...
... Named 2007 Medical Products Industry Leader, DEERFIELD, Ill., ... announced today that it has been named 2007,Medical Products ... World) and the Dow Jones Sustainability North America Index,(DJSI ... the,company has been listed in the DJSI and the ...
Cached Biology Technology:Genmab Discloses Target and Development Plans for HuMax-Inflam 2Genmab Discloses Target and Development Plans for HuMax-Inflam 3New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA 2New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA 3New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA 4Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year 2
Human Cell Line Slides...
... Signet offers the most comprehensive, cost-effective ... We have incorporated unprecedented quality into ... This includes proven detection chemistries and ... the TechMate protocol. It also includes ...
... 2 Detection System combines the indirect ... principle and Signets unique formulation of ... and reliablility. Signet reagents will achieve ... and automated protocols. ,Signets USA Detection ...
... Each Signet Level 2 Detection System ... avidin-biotin chemical bonding principle and Signets ... provide sensitivity, specificity and reliablility. Signet ... in both manual and automated protocols. ...
Biology Products: